Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes
Public ClinicalTrials.gov record NCT02537470. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-week Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Determine the Efficacy and Safety of Biphasic Remogliflozin Etabonate When Administered to Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a dose-ranging study to evaluate the efficacy, safety and tolerability of a range of doses of a biphasic formulation of remogliflozin etabonate compared to placebo, administered over 12 weeks in subjects with type 2 diabetes mellitus.
Study identification
- NCT ID
- NCT02537470
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 191 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2015 (Type not available)
- Primary completion
- Aug 2016 (Actual)
- Completion
- Aug 2016 (Actual)
- Last update posted
- Jan 18, 2018
2015 – 2016
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Arizona Clinical Research | Tucson | Arizona | 85712 | — |
| Long Beach Clinical Trials | Long Beach | California | 90806 | — |
| Long Beach Center for Clinical Research | Long Beach | California | 90807 | — |
| National Research Institute | Los Angeles | California | 90057 | — |
| Orange County Research Center | Tustin | California | 92780 | — |
| Diablo Clinical Research | Walnut Creek | California | 94598 | — |
| Chase Medical Research | Waterbury | Connecticut | 06708 | — |
| Medical Research Unlimited | Hialeah | Florida | 33012 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Meridien Research | Tampa | Florida | 33634 | — |
| eStudySite, Las Vegas | Las Vegas | Nevada | 89109 | — |
| Comprehensive Clinical Research | Berlin | New Jersey | 08009 | — |
| Albuquerque Clinical Trials, Inc | Albuquerque | New Mexico | 87102 | — |
| Mountain View Clinical Research | Greer | South Carolina | 29651 | — |
| New Phase Research & Development | Knoxville | Tennessee | 37909 | — |
| Austin Center for Clinical Research | Austin | Texas | 78756 | — |
| Padre Coast Clinical Research | Corpus Christi | Texas | 78404 | — |
| Juno Research, LLC | Houston | Texas | 77074 | — |
| Wasatch Clinical Research | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02537470, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 18, 2018 · Synced Oct 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02537470 live on ClinicalTrials.gov.